British American Tobacco (BAT) can be a hard sell, particularly to the increasing number of "woke" investors.

Globally — barring a handful of emerging markets — cigarette sales are steadily being stubbed out. There’s frankly not much to debate about the potential health hazards of tobacco, and more stringent smoking regulations are increasingly snuffing out the last vestiges of social acceptability. Not surprisingly, BAT’s share price, which traded at more than R900 in May 2017, is now back at levels seen in early 2014...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now